GB201808723D0 - Treatment of hyperproliferative disorders - Google Patents

Treatment of hyperproliferative disorders

Info

Publication number
GB201808723D0
GB201808723D0 GBGB1808723.9A GB201808723A GB201808723D0 GB 201808723 D0 GB201808723 D0 GB 201808723D0 GB 201808723 A GB201808723 A GB 201808723A GB 201808723 D0 GB201808723 D0 GB 201808723D0
Authority
GB
United Kingdom
Prior art keywords
treatment
hyperproliferative disorders
hyperproliferative
disorders
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1808723.9A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Birmingham
Original Assignee
University of Birmingham
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Birmingham filed Critical University of Birmingham
Priority to GBGB1808723.9A priority Critical patent/GB201808723D0/en
Publication of GB201808723D0 publication Critical patent/GB201808723D0/en
Priority to PCT/GB2019/051437 priority patent/WO2019229420A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
GBGB1808723.9A 2018-05-29 2018-05-29 Treatment of hyperproliferative disorders Ceased GB201808723D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1808723.9A GB201808723D0 (en) 2018-05-29 2018-05-29 Treatment of hyperproliferative disorders
PCT/GB2019/051437 WO2019229420A1 (en) 2018-05-29 2019-05-24 Treatment of hyperproliferative disorders

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1808723.9A GB201808723D0 (en) 2018-05-29 2018-05-29 Treatment of hyperproliferative disorders

Publications (1)

Publication Number Publication Date
GB201808723D0 true GB201808723D0 (en) 2018-07-11

Family

ID=62812547

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1808723.9A Ceased GB201808723D0 (en) 2018-05-29 2018-05-29 Treatment of hyperproliferative disorders

Country Status (2)

Country Link
GB (1) GB201808723D0 (en)
WO (1) WO2019229420A1 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012522762A (en) * 2009-04-01 2012-09-27 ザ メディカル リサーチ， インフラストラクチャー， アンド ヘルス サーヴィシーズ ファンド オブ ザ テル アヴィヴ メディカル センター Methods for regulating keratinocyte proliferation and differentiation
CN107106706B (en) * 2015-01-20 2021-10-08 安徽医科大学 lmo4 application of inhibitor of gene expression in preparing externally-applied psoriasis treatment medicine

Also Published As

Publication number Publication date
WO2019229420A1 (en) 2019-12-05

Similar Documents

Publication Publication Date Title
IL273693A (en) Treatment of inflammatory disorders
GB201804514D0 (en) Treatment of pyroptosis
ZA201903003B (en) Treatment of neurological diseases
IL267818A (en) Methods for the treatment of neurological disorders
EP3897641C0 (en) Treatment of movement disorders
IL270781A (en) Treatment of depressive disorders
IL269604A (en) Pantids for treatment of autoimmune disorders
IL270900A (en) Treatment of cutaneous disorders
GB201804515D0 (en) Treatment of necroptosis
GB201914034D0 (en) Treatment of neurological disorders
IL263080B (en) Treatment of neurological disorders
GB201607388D0 (en) Treatment of impulsivity-related disorders
GB201805100D0 (en) Treatment of sarcopenic diseases
GB201713760D0 (en) Treatment of epilepsy
IL282360A (en) Treatment of neurological diseases
GB201907305D0 (en) Treatment of conditions
GB201808723D0 (en) Treatment of hyperproliferative disorders
GB201812276D0 (en) Treatment of cognitive disorders
GB201917253D0 (en) Treatment of conditions
GB201809408D0 (en) Treatment of Cognitive Disorders
SG11202007642RA (en) Treatment of disorders with tasimelteon
IL290983A (en) Methods of treatment
GB201918853D0 (en) Methods of treatment
IL274132A (en) Treatment of skin disorders
GB201900942D0 (en) Methods of treatment

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)